Durham-based Avicenna raises $6 million for ALS drug research
The company previously raised $2.5 million in September 2020 and $3 million in December 2022, according to Crunchbase.
Read Moredrug research
Durham startup with quantum-based drug platform raises more cash
Polaris Quantum Biotech, which recently came out of stealth mode to launch a new drug discovery platform, has raised an additional $235,000 in equity, according to a securities filing.
Read More
NCSU, pharma firm create database focusing on large molecules, drug discovery
RALEIGH – Researchers from North Carolina State University and Collaborations Pharmaceuticals have created a free-to-use database of 14,000 known macrolactones – large molecules used in drug development – which contains information about the molecular characteristics, chemical diversity and biological activities of this structural class. The database, called MacrolactoneDB, fills a...
Read More
Morrisville-based Synteract acquires pediatric drug development firm
Synteract, a drug development company operating in Morrisville, has acquired KinderPharm, a pediatric drug development company, for an undisclosed amount to expand its pediatric drug operation.
Read More
Belgian investment company acquires Durham biotesting firm BioAgilytix
Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company.
Read More
NY investment fund pledges $65M to create new drug firm with UNC
UNC-Chapel Hill is partnering with New York-based Deerfield Management to create Pinnacle Hill LLC, a company seeking to discovery new medicines for unmet medical needs.
Read More
From drones to 3-D printed contraceptives: The innovation driving global health solutions
From drones to 3-D printed contraceptives, innovation and its impact on global health took center stage at the 4th annual Triangle Global Health Conference (TGHC) on Thursday.
Read More
RTP-based Verinetics expands anti-counterfeiting reach in pharma industry
RTP-based CertriRx recently started doing business as Verinetics. But the young company hasn’t changed its focus, or the speed with which it is making inroads in anti-counterfeiting technology.
Read MoreBioCryst reports positive drug trial results
A novel drug candidate aimed at preventing and treating hereditary angioedema (HAE) – a recurrent and severe swelling disorder – has shown positive results in a clinical trial, according to its Durham-based developer, BioCryst.
Read More- 1
- 2
